I am a breastfeeding mother and i want to know if it is safe to use 5-22-02-00360 (Beilstein Handbook Reference)? Is 5-22-02-00360 (Beilstein Handbook Reference) safe for nursing mother and child? Does 5-22-02-00360 (Beilstein Handbook Reference) extracts into breast milk? Does 5-22-02-00360 (Beilstein Handbook Reference) has any long term or short term side effects on infants? Can 5-22-02-00360 (Beilstein Handbook Reference) influence milk supply or can 5-22-02-00360 (Beilstein Handbook Reference) decrease milk supply in lactating mothers?
Minimal information exists on the use of 5-22-02-00360 (Beilstein Handbook Reference) during breastfeeding. Although some developmental problems have been reported in two infants exposed to 5-22-02-00360 (Beilstein Handbook Reference) in breastmilk, their mothers were also exposed to several drugs during pregnancy and during breastfeeding, so the problems cannot necessarily be attributed to 5-22-02-00360 (Beilstein Handbook Reference). If 5-22-02-00360 (Beilstein Handbook Reference) is required by the mother of an older infant, it is not a reason to discontinue breastfeeding, but until more data become available, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.
5-22-02-00360 (Beilstein Handbook Reference) was used as part of multidrug regimens to treat two pregnant women with multidrug-resistant tuberculosis, one throughout pregnancy and postpartum and the other postpartum only. The infants were breastfed (extent and duration not stated). At age 4.6 and 5.1 years, the children were developing normally except for a mild speech delay in one and hyperactivity in the other.[1]
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.